However the occurrence of uncommon inactivating IDH mutations, loss of heterozygosity of IDH in some tumors, and monoallelic expression of IDH1 in some gliomas points to as yet uncharacterized mechanisms of disease associated with IDH dysfunction. Here, IDH1 is linked to central nervous system cancer.